[go: up one dir, main page]

NO982414D0 - New combination - Google Patents

New combination

Info

Publication number
NO982414D0
NO982414D0 NO982414A NO982414A NO982414D0 NO 982414 D0 NO982414 D0 NO 982414D0 NO 982414 A NO982414 A NO 982414A NO 982414 A NO982414 A NO 982414A NO 982414 D0 NO982414 D0 NO 982414D0
Authority
NO
Norway
Prior art keywords
new combination
new
combination
Prior art date
Application number
NO982414A
Other languages
Norwegian (no)
Other versions
NO982414L (en
Inventor
Jan Trofast
Anders Ullman
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of NO982414D0 publication Critical patent/NO982414D0/en
Publication of NO982414L publication Critical patent/NO982414L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
NO982414A 1996-10-08 1998-05-27 New combination NO982414L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9603669A SE9603669D0 (en) 1996-10-08 1996-10-08 New combination
PCT/SE1997/001606 WO1998015280A1 (en) 1996-10-08 1997-09-24 New combination

Publications (2)

Publication Number Publication Date
NO982414D0 true NO982414D0 (en) 1998-05-27
NO982414L NO982414L (en) 1998-05-27

Family

ID=20404167

Family Applications (1)

Application Number Title Priority Date Filing Date
NO982414A NO982414L (en) 1996-10-08 1998-05-27 New combination

Country Status (18)

Country Link
EP (1) EP0871450A1 (en)
JP (1) JP2000502365A (en)
KR (1) KR19990071975A (en)
AR (1) AR013614A1 (en)
AU (1) AU715319B2 (en)
BR (1) BR9706822A (en)
CA (1) CA2239308A1 (en)
CZ (1) CZ176198A3 (en)
HU (1) HUP9901674A3 (en)
MY (1) MY128337A (en)
NO (1) NO982414L (en)
NZ (1) NZ330482A (en)
PL (1) PL327037A1 (en)
SE (1) SE9603669D0 (en)
SK (1) SK75198A3 (en)
TW (1) TW470647B (en)
WO (1) WO1998015280A1 (en)
ZA (1) ZA978889B (en)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5983956A (en) * 1994-10-03 1999-11-16 Astra Aktiebolag Formulation for inhalation
SE9700136D0 (en) * 1997-01-20 1997-01-20 Astra Ab New formulation
US5980949A (en) * 1994-10-03 1999-11-09 Astra Aktiebolag Formulation for inhalation
SE9700134D0 (en) * 1997-01-20 1997-01-20 Astra Ab New formulation
SE9700133D0 (en) * 1997-01-20 1997-01-20 Astra Ab New formulation
SE9700135D0 (en) 1997-01-20 1997-01-20 Astra Ab New formulation
WO1999000134A1 (en) * 1997-06-27 1999-01-07 Astra Aktiebolag (Publ) New combination of antiasthma medicaments
SE9703407D0 (en) 1997-09-19 1997-09-19 Astra Ab New use
SE9802073D0 (en) 1998-06-11 1998-06-11 Astra Ab New use
US6451285B2 (en) 1998-06-19 2002-09-17 Baker Norton Pharmaceuticals, Inc. Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant
US6290930B1 (en) 1998-12-18 2001-09-18 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes and budesonide
US6004537A (en) * 1998-12-18 1999-12-21 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol
SE9900834D0 (en) * 1999-03-09 1999-03-09 Astra Ab Novel combination
DE19921693A1 (en) * 1999-05-12 2000-11-16 Boehringer Ingelheim Pharma Pharmaceutical composition for treating respiratory disorders, e.g. asthma, comprises combination of anticholinergic and beta-mimetic agents having synergistic bronchospasmolytic activity and reduced side-effects
ES2165768B1 (en) 1999-07-14 2003-04-01 Almirall Prodesfarma Sa NEW DERIVATIVES OF QUINUCLIDINE AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
GB0009584D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Pharmaceutical compositions
GB0012260D0 (en) * 2000-05-19 2000-07-12 Astrazeneca Ab Novel composition
FI20002216A0 (en) 2000-10-06 2000-10-06 Orion Yhtymae Oyj Combination particles for asthma therapy
US6667344B2 (en) 2001-04-17 2003-12-23 Dey, L.P. Bronchodilating compositions and methods
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
SE0200312D0 (en) 2002-02-01 2002-02-01 Astrazeneca Ab Novel composition
SE527069C2 (en) 2003-06-19 2005-12-13 Mederio Ag Method and apparatus for administering drug powder
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
US20050026887A1 (en) * 2003-07-29 2005-02-03 Boehringer Ingelheim International Gmbh Medicaments for inhalation comprising an anticholinergic and a steroid
JP5508003B2 (en) 2006-06-30 2014-05-28 アイスイティカ ピーティーワイ リミテッド Process for the preparation of biologically active compounds in nanoparticulate form
AU2008217586A1 (en) 2007-02-19 2008-08-28 Cipla Limited Pharmaceutical combinations of at least two bronchodilators or of a bronchodilator with a corticosteroid
EP2100599A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
KR20120015334A (en) 2009-05-29 2012-02-21 펄 테라퓨틱스 인코포레이티드 Compositions for Respiratory Delivery of Active Agents, and Associated Methods and Systems
EP2510928A1 (en) 2011-04-15 2012-10-17 Almirall, S.A. Aclidinium for use in improving the quality of sleep in respiratory patients
CA2856520C (en) 2011-11-23 2021-04-06 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
CN107875127A (en) * 2012-02-28 2018-04-06 艾塞尤提卡控股公司 Inhalable drug composition
ITMI20130571A1 (en) 2013-04-10 2014-10-11 Zambon Spa PHARMACEUTICAL COMPOSITION CONTAINING BUDESONIDE AND FORMOTEROL
IT202000006442A1 (en) 2020-03-27 2021-09-27 Genetic S P A BUDESONIDE 21-PHOSPHATE SALTS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT613371E (en) * 1991-12-18 2002-07-31 Astrazeneca Ab NEW COMBINATION OF FORMOTEROL AND BUDSONIDO

Also Published As

Publication number Publication date
NZ330482A (en) 1999-11-29
AU715319B2 (en) 2000-01-20
TW470647B (en) 2002-01-01
PL327037A1 (en) 1998-11-09
JP2000502365A (en) 2000-02-29
KR19990071975A (en) 1999-09-27
CA2239308A1 (en) 1998-04-16
HUP9901674A3 (en) 2001-04-28
ZA978889B (en) 1998-04-08
HUP9901674A2 (en) 1999-09-28
AU4578297A (en) 1998-05-05
AR013614A1 (en) 2001-01-10
CZ176198A3 (en) 1998-09-16
SE9603669D0 (en) 1996-10-08
NO982414L (en) 1998-05-27
WO1998015280A1 (en) 1998-04-16
SK75198A3 (en) 1998-11-04
BR9706822A (en) 1999-03-23
EP0871450A1 (en) 1998-10-21
MY128337A (en) 2007-01-31

Similar Documents

Publication Publication Date Title
NO982414D0 (en) New combination
NO20001830D0 (en) New combination
BR9703884A (en) Cycloalkanopyridines
BR9704464A (en) Eviscerator
BR9707851A (en) Quinoxaliniones
ATE353652T1 (en) ESTROPROGESTATIVE CONTRACEPTIONAL
KR980000769U (en) condition
BR9703563A (en) Hydromancal
BR9707467A (en) 1-Pyrazol-3-ylethyl-4-indole-3-ylpiperdins
BR9703835A (en) Hydromancal
BR9711681A (en) New m-all
BR9708716A (en) 3-cyanoaryl-pyrazoles
FI2776U1 (en) Hängselkonstruktion
BR9603975A (en) Fix-catch
BR9600914A (en) Lipodecantador
BR9606119A (en) Heliceboy
BR9605529A (en) Banzo
BR9605291A (en) Hydro-collection
BR9604479A (en) Gongorremo
BR9604349A (en) Xapisqueira
BR9603978A (en) Confort-let
BR9603977A (en) Fix-ped
BR9603976A (en) Stop-clog
FI964454A0 (en) Uppkopplingsmatris
BR9603887A (en) Fix-imobi

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application